Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Macrophage Therapeutics, |
Description | Home Our Approach Therapeutic Areas of Focus Our Delivery System Contact Delivering Precise and Targeted Therapeutics Macrophage Therapeutics (MT) is deve |
Keywords | N/A |
WebSite | macrophagetx.com |
Host IP | 54.208.101.55 |
Location | United States |
Site | Rank |
US$302,653
Last updated: 2023-05-13 15:39:29
macrophagetx.com has Semrush global rank of 34,971,852. macrophagetx.com has an estimated worth of US$ 302,653, based on its estimated Ads revenue. macrophagetx.com receives approximately 34,922 unique visitors each day. Its web server is located in United States, with IP address 54.208.101.55. According to SiteAdvisor, macrophagetx.com is safe to visit. |
Purchase/Sale Value | US$302,653 |
Daily Ads Revenue | US$280 |
Monthly Ads Revenue | US$8,382 |
Yearly Ads Revenue | US$100,574 |
Daily Unique Visitors | 2,329 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
macrophagetx.com. | A | 600 | IP: 54.208.101.55 |
macrophagetx.com. | NS | 3600 | NS Record: ns61.domaincontrol.com. |
macrophagetx.com. | NS | 3600 | NS Record: ns62.domaincontrol.com. |
macrophagetx.com. | MX | 3600 | MX Record: 0 macrophagetx-com.mail.protection.outlook.com. |
macrophagetx.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
macrophagetx.com. | TXT | 600 | TXT Record: MS=ms17178176 |
macrophagetx.com. | TXT | 600 | TXT Record: v=verifydomain MS=4159301 |
Home Our Approach Therapeutic Areas of Focus Our Delivery System Contact Delivering Precise and Targeted Therapeutics Macrophage Therapeutics (MT) is developing novel immuno-oncology and targeted anti-inflammatory therapeutics based on its proprietary Activated Macrophage targeting platform. MT is leveraging its unique CD206 receptor-based delivery system to deliver proven therapeutics in a more precise and targeted fashion. With binding affinities 10,000X today’s best antibodies MT’s approach eliminates off-target toxicity and increases the efficacy of proven therapeutic agents. MT’s CD206 targeting platform is already clinically established and being used in an FDA/EMEA approved radiopharmaceutical. View Our Approach Anti-inflammatory Macrophage Therapeutics has developed a proprietary targeted steroid (MT-2000 class) designed to specifically treat the disease-causing cells quarterbacking the body’s inflammatory response (Macrophages). MT-2000 is a class of agents that are designed |
HTTP/1.1 301 Moved Permanently Date: Tue, 21 Dec 2021 16:33:28 GMT Server: Apache Location: http://www.macrophagetx.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 302 Moved Temporarily Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Content-Type: text/html; charset=UTF-8 Date: Tue, 21 Dec 2021 16:33:28 GMT Expires: Thu, 19 Nov 1981 08:52:00 GMT Location: https://www.macrophagetx.com/ Pragma: no-cache Server: Apache Connection: keep-alive HTTP/1.1 200 OK Date: Tue, 21 Dec 2021 16:33:28 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Content-Type: text/html; charset=UTF-8 |
Domain Name: MACROPHAGETX.COM Registry Domain ID: 1937193844_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-06-10T19:43:45Z Creation Date: 2015-06-09T21:23:27Z Registry Expiry Date: 2022-06-09T21:23:27Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS61.DOMAINCONTROL.COM Name Server: NS62.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:14:58Z <<< |